Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 4, 2008, Pages 707-722

  Trefi, Saleh ^a   Gilard, Véronique ^a   Balayssac, Stéphane ^a   Malet Martino, Myriam ^a   Martino, Robert ^a  

^a UPS)   (France)

Author keywords

Cyclodextrin; 2D DOSY 1H NMR; 19F NMR; Fluoxetine; Fluvoxamine

Indexed keywords

ADOFEN; ANTIDEPRESSANT AGENT; ASTRIN; DIBENZEPIN; FLUNAT; FLUOCIM; FLUOXETINE; FLUOXIN; FLUPENTIXOL; FLUVOXAMINE; FLUVOXAMINE MALEATE; FLUZAC; HALOPERIDOL; LOFTIL; METHANOL; NUZAC; OXEDAP; PRODAC; PROUZIAC; PROXETIN; QUINOLONE DERIVATIVE; SALIDEP; TRIZAC; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD; DIFFUSION ORDERED SPECTROSCOPY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; INTERNET; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; SENSITIVITY ANALYSIS; SPECTROSCOPY; URINE;

BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; FLUOXETINE; FLUVOXAMINE; HUMANS; INTERNET; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 39149109283     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.038     Document Type: Article

References (43)

1. Berzas J., Guiberteau C., Contento A.M., and Rodriguez V. Chromatographia 56 (2002) 545-551
2. Raggi M.A., Bugamelli F., Casamenti G., Mandrioli R., De Ronchi D., and Volterra V. J. Pharm. Biomed. Anal. 18 (1998) 699-706
3. Ertürk S., Cetil S.M., Atmaca S., Ersoy L., and Baktir G. Ther. Drug Monit. 27 (2005) 38-43
4. Sarracíno M.A., Mercolini L., Flotta G., Albers L.J., Merli R., and Raggi M.A. J. Chromatogr. B 843 (2006) 227-233
5. Shinozuka T., Terada M., and Tanaka E. Forensic Sci. Int. 162 (2006) 108-112
6. Kirchherr H., and Kühn-Velten W.N. J. Chromatogr. B 843 (2006) 100-113
7. Fernández C., dos Santos Neto A.J., Rodrigues J.C., Alves C., and Lanças F.M. J. Chromatogr. B 847 (2007) 217-223
8. Ulu S.T. J. Pharm. Biomed. Anal. 43 (2007) 1444-1451
9. Berzas Nevado J.J., Villaseñor Llerena M.J., Guiberteau Cabanillas C., Rodriguez Robledo V., and Buitrago S. J. Sep. Sci. 29 (2006) 103-113
10. Berzas Nevado J.J., Villaseñor Llerena M.J., Guiberteau Cabanillas C., and Rodriguez Robledo V. J. Chromatogr. A 1123 (2006) 130-133
11. Salgado-Petinal C., Lamas J.P., Garcia-Jares C., Llompart M., and Cela R. Anal. Bioanal. Chem. 382 (2005) 1351-1359
12. Berzas Nevado J.J., Villaseñor Llerena M.J., Contento Salcedo A.M., and Aguas Nuevo E. J. Pharm. Biomed. Anal. 38 (2005) 52-59
13. Flores J.R., Berzas Nevado J.J., Contento Salcedo A.M., and Cabello Diaz M.P. J. Sep. Sci. 27 (2004) 33-40
14. Flores J.R., Berzas Nevado J.J., Castañeda Peñalvo G., and Mora Diez N. Talanta 65 (2005) 163-171
15. Afkhami A., Madrakian T., and Khalafi L. Chem. Pharm. Bull. 54 (2006) 1642-1646
16. Malz F., and Jancke H. J. Pharm. Biomed. Anal. 38 (2005) 813-823
17. Martino R., Gilard V., Desmoulin F., and Malet-Martino M. J. Pharm. Biomed. Anal. 38 (2005) 871-891 (and references cited)
18. Diehl B.W.K., Malz F., and Holzgrabe U. Spectrosc. Eur. 19 (2007) 15-19
19. Hull W.E., Port R.E., Herrmann R., Britsch B., and Kunz W. Cancer Res. 48 (1988) 1680-1688
20. Fardella G., Barbetti P., Chiappini I., and Grandolini G. Acta Technol. et Legis Med. 4 (1993) 89-96
21. Fardella G., Barbetti P., Chiappini I., and Grandolini G. Int. J. Pharm. 121 (1995) 123-127
22. Reigner B., Clive S., Cassidy J., Jodrell D., Schulz R., Goggin T., Banken L., Roos B., Utoh M., Mulligan T., and Weidekamm E. Cancer Chemother. Pharmacol. 43 (1999) 309-315
23. Talebpour Z., Haghgoo S., and Shamsipur M. Anal. Biochem. 323 (2003) 205-210
24. Shamsipur M., Shafiee-Dastgerdi L., Talebpour Z., and Haghgoo S. J. Pharm. Biomed. Anal. 43 (2007) 1116-1121
25. Trefi S., Gilard V., Malet-Martino M., and Martino R. J. Pharm. Biomed. Anal. 44 (2007) 743-754
26. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: text and methodology Q2(R1), International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005) 1-13.
27. Deubner R., and Holzgrabe U. Magn. Reson. Chem. 40 (2002) 762-766
28. Ali S.M., Asmat F., Maheshwari A., and Koketsu M. Il Farmaco 60 (2005) 445-449
29. Fux P. Analyst 115 (1990) 179-183
30. Berzas Nevado J.J., Villaseñor Llerena M.J., Contento Salcedo A.M., and Aguas Nuevo E. J. Chromatogr. Sci. 38 (2000) 200-206
31. Berzas J.J., Guiberteau C., Villaseñor M.J., and Rodríguez V. Anal. Chim. Acta 519 (2004) 219-230
32. Berzas Nevado J.J., Contento Salcedo A.M., Villaseñor Llerena M.J., and Aguas Nuevo E. Anal. Chim. Acta 417 (2000) 169-176
33. Mandrioli R., Pucci V., Visini D., Varani G., and Raggi M.A. J. Pharm. Biomed. Anal. 29 (2002) 1127-1134
34. Prabhakar A.H., Patel V.B., and Giridhar R. J. Pharm. Biomed. Anal. 20 (1999) 427-432
35. Starczewska B., Jasinska A., and Bialous B. Pharmazie 58 (2003) 245-248
36. Buzinkaiova T., and Polonsky J. Electrophoresis 21 (2000) 2839-2841
37. Nouws H.P.A., Delerue-Matos C., Barros A.A., Rodrigues J.A., and Santos-Silva A. Anal. Bioanal. Chem. 382 (2005) 1662-1668
38. Musshoff F., Padosch S., Steinborn S., and Madea B. Forensic Sci. Int. 142 (2004) 161-210
39. Hull W.E. Bruker Rep. 2 (1986) 15-19
40. Béteille J.P., Lopez A., Bon M., Malet-Martino M.C., and Martino R. Anal. Chim. Acta 171 (1985) 225-231
41. US Pharmacopeia, 23rd Edition, 7th Supplement, US Pharmacopeial Convention, Rockville, MD (1997) 3890.
42. Forget R., and Spagnoli S. J. Pharm. Biomed. Anal. 41 (2006) 1051-1055
43. Abdel-Shafi A.A. Spectrochim. Acta Part A 66 (2007) 732-738